FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly ophthalmology, and may be used for treating peripheral and central tapetoretinal dystrophies. That is ensured by 5-10 procedures of the parabulbar introduction of α-fetoprotein 34-75 mcg in isotonic solution 1-3 ml in each eye once in 1-4 days. It is followed by the sequential parabulbar and retrobulbar injections of equal proportions of a suspension containing 10 mln. autologous mononuclears recovered from bone marrow. Bone marrow is taken 1-1.5 hours before the introduction.
EFFECT: method provides an integrated effect on pathological processes in eye socket tissues with inducing organotypic regeneration and providing considerable and stable improvement of visual functions.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING WET AGE-RELATED MACULAR DEGENERATION OF RETINA WITH USING CELL TRANSPLANTATION | 2011 |
|
RU2467727C2 |
METHOD OF TREATING OPTIC NERVE BY TRANSPLANTATION OF AUTOLOGIC STEM CELLS | 2009 |
|
RU2428956C2 |
METHOD OF INCREMENT IN RETINA CAPACITY WITH VARIOUS PATHOLOGIES | 2008 |
|
RU2364382C1 |
AGENT RECOVERING RETINA EYE FUNCTION | 1993 |
|
RU2073518C1 |
METHOD OF TREATING DYSTROPHIC DISEASES OF POSTERIOR EYE POLE | 2010 |
|
RU2435556C1 |
TETRAPEPTIDE STIMULATING EYE RETINA FUNCTION, PHARMACOLOGICAL AGENT BASED ON THEREOF AND METHOD OF ITS USING | 2000 |
|
RU2161982C1 |
METHOD OF TREATING INFLAMMATORY OR DYSTROPHIC EYE DISEASES | 2019 |
|
RU2714193C1 |
METHOD OF INCREASING EFFECIENCY OF PHOTODYNAMIC THERAPY OF CHOROIDAL NEOVASCULARISATION | 2008 |
|
RU2375023C1 |
METHOD OF TREATMENT OF CHOROIDAL NEOVASCULATION | 2018 |
|
RU2676075C1 |
THREE-COMPONENT COMPLEX FOR CELL THERAPY IN OPHTHALMOLOGY | 2012 |
|
RU2495650C1 |
Authors
Dates
2012-11-27—Published
2011-01-19—Filed